Cellectar Biosciences (NASDAQ:CLRB) Earns Sell Rating from Analysts at Wall Street Zen
Wall Street Zen assumed coverage on shares of Cellectar Biosciences (NASDAQ:CLRB – Get Free Report) in a research report issued on Wednesday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Separately, Maxim Group restated a “hold” rating on shares of Cellectar Biosciences in a research report on Wednesday, May 14th. Get Our […]
Wall Street Zen assumed coverage on shares of Cellectar Biosciences (NASDAQ:CLRB – Get Free Report) in a research report issued on Wednesday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Separately, Maxim Group restated a “hold” rating on shares of Cellectar Biosciences in a research report on Wednesday, May 14th. Get Our […]
